First Quantum reported a strong Q3, with copper production rising 13% quarter-over-quarter despite Cobre Panama's suspension. Higher grades at Kansanshi and Sentinel reduced C1 cash costs by $0.16, strengthening margins, while gold production surged 20% QoQ, boosting revenue alongside resilient copper prices and record gold prices. Cobre Panama remains a key asset, with ongoing arbitration claims that could unlock significant upside. The market appears to be undervaluing the potential outcomes regarding the Cobre Panama mine closure.
TORONTO, ON / ACCESSWIRE / October 29, 2024 / Quantum BioPharma Ltd. (NASDAQ:QNTM)(CSE:QNTM)(FRA:0K91) ("Quantum BioPharma" or the "Company"), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, today announces through its subsidiary, HUGE Biopharma Australia Pty Ltd.
Quantum computing is a revolutionary, next-generation technology used to solve complex equations. Stock Strategist Andrew Rocco explains that though its in its early stages, quantum computing is likely to disrupt several industries.
Quantum computing stocks to check out in the stock market right now.
These firms are building technology that could upend the computer industry.
TORONTO, ON / ACCESSWIRE / October 7, 2024 / Quantum BioPharma Ltd. (NASDAQ:QNTM)(CSE:QNTM)(FRA:0K91) ("Quantum BioPharma"), provides an update by way of a news release issued by Celly Nutrition Corp. ("Celly Nu" or the "Company"), and its launching of unbuzzd™, an innovative beverage product that is scientifically formulated from a proprietary blend of vitamins, minerals and botanical extracts designed to support the body's natural processes for metabolizing alcohol and promoting alertness.
QMCO strengthens its Veeam Ready qualifications to combat cyber threats and data recovery challenges effectively.
TORONTO, ON / ACCESSWIRE / September 27, 2024 / Quantum BioPharma Ltd. (formerly, FSD Pharma Inc.) (NASDAQ:QNTM)(CSE:QNTM)(FRA:0K91) ("Quantum BioPharma" or the "Company"), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, is pleased to announce the following corporate updates.
TORONTO, ON / ACCESSWIRE / September 25, 2024 / Quantum BioPharma Ltd. (formerly, FSD Pharma Inc.) (NASDAQ:QNTM)(CSE:QNTM)(FRA:0K91) ("Quantum BioPharma" or the "Company"), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, is pleased to announce that Jason Sawyer, Head of Finance and Mergers and Acquisitions, will present at the ArcStone-Kingswood Growth Summit held on September 26, 2024, in Toronto, ON.
Revolutionizing the Future of Quantum Computing and AI with Industry Luminary Dr. Wolf Kohn NEW YORK, NY / ACCESSWIRE / September 24, 2024 / Spectral Capital Corporation (OTCQB:FCCN), a trailblazer in Quantum-as-a-Service (QaaS) and decentralized cloud infrastructure, is thrilled to announce the appointment of Dr. Wolf Kohn, Ph.D., a globally recognized leader in quantum computing, artificial intelligence, and data optimization, to its Quantum Bridge Advisory Board.
Canadian miner First Quantum Minerals has opened a voluntary retirement (VR) scheme to workers at the Cobre Panama mine, two sources familiar with the matter told Reuters, as the company waits for a government decision on re-opening the facility.
TORONTO, ON / ACCESSWIRE / September 9, 2024 / Quantum BioPharma Ltd. (NASDAQ:QNTM)(CSE:QNTM)(FRA:0K91) ("Quantum BioPharma" or the "Company"), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, today announces that through its subsidiary, HUGE Biopharma Australia Pty Ltd.